MyJournals Home  

RSS FeedsSafety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation (Bone Marrow Transplantation)

 
 

28 august 2018 05:00:07

 
Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation (Bone Marrow Transplantation)
 






Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
32 viewsCategory: Medicine, Pathology
 
Health care utilization and cost among pediatric patients receiving unrelated donor allogeneic hematopoietic cell transplantation (Bone Marrow Transplantation)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2018 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn